H.-L. Zhang et al. / Carbohydrate Research 354 (2012) 32–39
37
insights into the future design and construction of triazolyl glyco-
lipid derivatives as potential corrosion inhibitors.
3.75 (t, J = 9.1 Hz, 1H), 3.71 (m, 1H), 3.69–3.60 (m, 3H), 3.49 (t,
J = 6.6 Hz, 2H), 3.47 (dd, J = 8.8, 3.7 Hz, 1H), 3.27 (t, J = 9.3 Hz,
1H), 1.56 (m, 2H), 1.26 (br s, 18H), 0.87 (t, J = 6.8 Hz, 3H); 13C
NMR (100 MHz, CDCl3 + CD3OH) d 144.6, 123.3, 100.9, 87.5, 77.7,
76.5, 73.5, 72.9, 72.2, 71.1, 69.5, 63.6, 60.9, 60.6, 57.8, 31.8, 29.6,
29.5, 29.5, 29.4, 29.3, 29.2, 25.9, 22.5, 17.9, 13.9; HR-ESI-MS m/z:
calcd for C27H49N3O11 + H 592.3445, found 592.3441.
4. Experimental section
4.1. Synthesis
Solvents were purified by standard procedures. Petroleum ether
(PE) used refers to the fraction boiling in the range 60–90 °C. 1H and
13C NMR spectra were recorded on a Bruker AM-400 spectrometer
in CDCl3, D2O or CD3OD solutions using TMS as the internal stan-
dard (chemical shifts in parts per million). Standard abbreviations
are used to describe the signal multiplicity. All reactions were mon-
itored by TLC (Yantai Marine Chemical Co. Ltd, China). High resolu-
tion mass spectra (HRMS) were recorded on a Waters LCT Premier
XE spectrometer using standard conditions (ESI, 70 eV). Analytical
HPLC was measured using Agilent 1100 Series equipment.
4.1.2. Synthesis of [1-(2,3,4-Tri-O-benzyl-6-O-propargyl-b-D-
glucopyranosyl)-1H-1,2,3-triazol-4-yl]methyl n-dodecyl ether
(e2)
To a well-stirred solution of e1 (400 mg, 0.93 mmol) in pyridine
(7 mL) at 0 °C were added TBDMSCl (196.4 mg, 1.30 mmol) and
DMAP (45.5 mg, 0.37 mmol). The mixture was then allowed to
reach rt and stirred for 6 h. The resulting mixture was concentrated
under reduced pressure and the residue was diluted with CH2Cl2
and washed successively with 1 N HCl and 5% aq NaHCO3. The
combined organic layer was dried over MgSO4 and concentrated
under reduced pressure to give a crude product which was dis-
4.1.1. General procedure for the synthesis of compounds 28–30
To a well-stirred biphasic solution of the per-O-acetylated gly-
cosyl azide (1 equiv) and the alkynyl ether (2 equiv) in CH2Cl2
(8–10 mL) and H2O (6 mL), were added CuSO4Á5H2O (1.5 equiv)
and sodium ascorbate (2.5 equiv), and this mixture was stirred at
rt for 6 h. The resulting mixture was diluted with CH2Cl2 and then
washed with brine. The combined organic layer was dried over
MgSO4 and then concentrated under reduced pressure to give a
crude residue which was directly dissolved in MeOH/Et3N/H2O
(8:1:1, V/V/V) and stirred overnight at rt. The resulting solution
was concentrated to dryness to give a thick syrup which was puri-
fied by column chromatography.
solved in DMF (8 mL). BnBr (443.8 lL, 3.72 mmol) was added and
the resulting solution was cooled to 0 °C, followed by addition of
60% NaH (148.8 mg, 3.72 mmol) in 3 batches. After stirring at rt
for 2 h, the reaction was quenched with MeOH (2 mL) and the mix-
ture was concentrated in vacuum. The residue was diluted with
EtOAc and washed successively with 1 N HCl and brine. The organ-
ic layer was combined, dried over MgSO4 and concentrated under
reduced pressure. The resulting crude residue was dissolved in
MeOH (12 mL) and cooled to 0 °C. AcCl (329.2 lL, 4.66 mmol)
was added dropwise and the mixture was stirred at rt for 1 h.
The resulting mixture was concentrated under reduced pressure
and the resulting residue was dissolved directly in DMF (8 mL), fol-
lowed by addition of propargyl bromide (109.3 lL, 1.40 mmol). The
4.1.1.1. (1-b-
ether (28).
D
-Maltosyl-1H-1,2,3-triazol-4-yl)methyl n-hexyl
From b (217.4 mg, 0.329 mmol) and a1 (92.2 mg,
resulting mixture was cooled to 0 °C and 60% NaH (56.0 mg,
1.40 mmol) was added. After stirring at rt for 6 h, H2O (8 mL)
was added and the mixture was concentrated under reduced pres-
sure. The resulting residue was diluted with EtOAc and washed
with brine. The combined organic layers were dried over MgSO4,
concentrated under reduced pressure and eventually purified by
column chromatography (petroleum ether–EtOAc, 6:1?2:1) to
give e2 (492.3 mg, 71.7% over 4 steps) as a white crystalline solid.
TLC: Rf = 0.60 (petroleum ether–EtOAc, 2:1). 1H NMR (400 MHz,
CDCl3) d 7.58 (s, 1H), 7.30–7.20 (m, 10H), 7.16–7.10 (m, 3H), 6.88
(dd, J = 6.6, 2.8 Hz, 2H), 5.51 (d, J = 9.1 Hz, 1H), 4.86 (s, 2H), 4.83
(d, J = 10.8 Hz, 1H), 4.68 (d, J = 10.8 Hz, 1H), 4.55 (dd, J = 15.2,
12.8 Hz, 2H), 4.41 (d, J = 10.5 Hz, 1H), 4.13 (dd, J = 15.9, 2.4 Hz,
1H), 4.03 (dd, J = 15.9, 2.3 Hz, 1H), 3.98 (dd, J = 16.0, 9.7 Hz, 2H),
3.81–3.71 (m, 3H), 3.67 (dd, J = 10.9, 1.5 Hz, 1H), 3.65–3.60 (m,
1H), 3.42 (t, J = 6.7 Hz, 2H), 2.31 (t, J = 2.3 Hz, 1H), 1.50 (m, 2H),
1.17 (br s, 18H), 0.81 (t, J = 6.8 Hz, 3H).
0.66 mmol), column chromatography (CH2Cl2–EtOH, 3:1?3:2)
afforded 28 as a white solid (137.3 mg, 82.2%). TLC: Rf = 0.60
(CH2Cl2–MeOH, 1:1). 1H NMR (400 MHz, D2O) d 8.28 (s, 1H), 5.80
(d, J = 8.5 Hz, 1H), 5.51 (d, J = 3.8 Hz, 1H), 4.70 (s, 2H), 4.09–4.00
(m, 2H), 3.95 (d, J = 12.0 Hz, 1H), 3.92–3.87 (m, 3H), 3.86 (d,
J = 13.4 Hz, 1H), 3.82–3.70 (m, 3H), 3.63 (dd, J = 10.0, 4.0 Hz, 1H),
3.61 (t, J = 6.8 Hz, 2H), 3.46 (t, J = 9.4 Hz, 1H), 1.59 (m, 2H), 1.36–
1.23 (br m, 6H), 0.86 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, D2O)
d 144.5, 123.9, 99.9, 87.3, 77.5, 76.4, 76.2, 72.9, 72.8, 72.2, 71.8,
70.7, 69.3, 63.0, 60.5, 60.4, 31.4, 29.0, 25.3, 22.3, 13.5; HR-ESI-MS
m/z: calcd for C21H37N3O11 + H 508.2506, found 508.2504.
4.1.1.2. (1-b-
ether (29).
D
-Maltosyl-1H-1,2,3-triazol-4-yl)methyl n-octyl
From b (203.9 mg, 0.31 mmol) and a2 (103.7 mg,
0.62 mmol), column chromatography (CH2Cl2–EtOH, 3:1?3:2)
afforded 29 as a white solid (141.2 mg, 85.6%). TLC: Rf = 0.68
(CH2Cl2–MeOH, 1:1). 1H NMR (400 MHz, D2O) d 8.15 (s, 1H), 5.71
(d, J = 7.7 Hz, 1H), 5.45 (d, J = 3.0 Hz, 1H), 4.54 (s, 2H), 4.00 (m,
2H), 3.91–3.81 (m, 4H), 3.75 (m, 4H), 3.62 (dd, J = 10.0, 3.1 Hz,
1H), 3.53–3.42 (m, 3H), 1.57 (br s, 2H), 1.30 (br s, 10H), 0.89 (t,
J = 6.0 Hz, 3H); 13C NMR (100 MHz, D2O + CD3OH) d 144.6, 123.9,
100.2, 87.5, 77.7, 76.6, 73.1, 72.9, 72.3, 72.0, 70.9, 69.4, 63.4, 60.7,
60.6, 32.0, 29.6, 29.4, 26.1, 22.8, 14.0; HR-ESI-MS m/z: calcd for
4.1.3. Synthesis of 4-{4-[(4-n-Dodecyloxymethyl-1H-1,2,3-
triazol-1-yl)b-D-glucopyranosd-6-yloxy]methyl-1H-1,2,3-
triazol-1-yl} benzenesulfonamide (31)
To a well-stirred biphasic solution of e2 (106 mg, 0.14 mmol)
and d (42.7 mg, 0.22 mmol) in CH2Cl2/H2O/acetone (10:5:1, V/V/
V) were added CuSO4Á5H2O (107.6 mg, 0.43 mmol) and sodium
ascorbate (170.7 mg, 0.86 mmol), and the mixture was stirred at
30 °C for 6 h. The resulting mixture was then diluted with CH2Cl2
and washed with saturated aq ethylene diamine tetraacetic acid
(EDTA) and brine. The combined organic layer was dried over
MgSO4 and concentrated under reduced pressure to give a crude
residue. This was then dissolved in MeOH/CH2Cl2 (2:1, V/V) and
PdCl2 (10 mg, 0.0564 mmol) was added. The mixture was stirred
vigorously under hydrogen atmosphere at 35 °C for 1 h. The result-
ing mixture was then filtered and concentrated under reduced
pressure. The resulting crude residue was purified by column chro-
C23H41N3O11 + H 536.2819, found 536.2820.
4.1.1.3. (1-b-
ether (30).
D
-Maltosyl-1H-1,2,3-triazol-4-yl)methyl n-dodecyl
From b (177.5 mg, 0.27 mmol) and a3 (120.4 mg,
0.54 mmol), column chromatography (CH2Cl2–EtOH, 3:1?2:1)
afforded 30 as a white solid (124.6 mg, 78.6%). TLC: Rf = 0.69
(CH2Cl2–MeOH, 1:1). 1H NMR (400 MHz, CD3OD) d 8.15 (s, 1H),
5.62 (d, J = 9.1 Hz, 1H), 5.23 (d, J = 3.7 Hz, 1H), 4.57 (s, 2H), 3.94
(t, J = 9.1 Hz, 1H), 3.87 (dd, J = 14.5, 2.2 Hz, 2H), 3.82 (m, 2H),